During the past decade, DRK Kliniken Berlin-Köpenick conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 2 clinical trials were completed, i.e. on average, 20% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 1 clinical trials were completed. i.e. 16.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "DRK Kliniken Berlin-Köpenick" #1 sponsor was "Abbott Medical Devices" with 1 trials, followed by "Actelion" with 1 trials sponsored, "Assistance Publique - Hôpitaux de Paris" with 1 trials sponsored, "Canadian Cancer Trials Group" with 1 trials sponsored and "Charite University, Berlin, Germany" with 1 trials sponsored. Other sponsors include 4 different institutions and companies that sponsored additional 14 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "DRK Kliniken Berlin-Köpenick" #1 collaborator was "AstraZeneca" with 2 trials as a collaborator, "Canadian Institutes of Health Research (CIHR)" with 2 trials as a collaborator, "Arbeitsgemeinschaft Gynaekologische Onkologie Austria" with 1 trials as a collaborator, "Arbeitsgemeinschaft Gynaekologische Onkologie Studiengruppe Ovarialkarzinom Germany" with 1 trials as a collaborator and "Astellas Pharma Inc" with 1 trials as a collaborator. Other collaborators include 24 different institutions and companies that were collaborators in the rest 34 trials.

According to Clinical.Site data, the most researched conditions in "DRK Kliniken Berlin-Köpenick" are "Cardiovascular Disease" (1 trials), "Cervical Cancer" (1 trials), "Chronic Heart Failure" (1 trials), "Chronic Lymphocytic Leukemia" (1 trials) and "Colorectal Cancer" (1 trials). Many other conditions were trialed in "DRK Kliniken Berlin-Köpenick" in a lesser frequency.

Most popular intervention types in "DRK Kliniken Berlin-Köpenick" are "Drug" (8 trials), "Device" (3 trials), "Other" (3 trials), "Biological" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "Acalabrutinib" (1 trials), "Alteplase" (1 trials), "Bevacizumab" (1 trials) and "Cardiovascular Polypill" (1 trials). Other intervention names were less common.

The vast majority of trials in "DRK Kliniken Berlin-Köpenick" are 12 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "DRK Kliniken Berlin-Köpenick". undefined are not yet recruiting, 4 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in DRK Kliniken Berlin-Köpenick, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in DRK Kliniken Berlin-Köpenick, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".